Frequency and clinical features of BRAF mutations among patients with stage III/IV lung adenocarcinoma without EGFR/ALK aberrations

Cheol Kim, Ho; Rim Kang, Yeh; Ji, Wonjun; Joo Kim, Yeon; Yoon, Shinkyo; Cheol Lee, Jae; Choi, Chang‐Min

doi:10.2147/ott.s213928

Public

Frequency and clinical features of BRAF mutations among patients with stage III/IV lung adenocarcinoma without EGFR/ALK aberrations

Published in OncoTargets and Therapy • Jul 1, 2019

Authors:

Ho Cheol Kim

Yeh Rim Kang

Wonjun Ji

Abstract

Purpose: BRAF mutations are found in 1–5% of non-small cell lung cancers, particularly adenocarcinomas. However, information regarding this mutation is limited in patients without EGFR/ALK aberrations, who have limited treatment options. Patients and methods: The medical records of 224 stage III/IV ...

Subject

Stage (stratigraphy)

Medicine

Adenocarcinoma

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!